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E-mail: ePeptides modified by pyridoxal-5(-phosphate (PLP), linked to a lysine residue via reductive amin-
ation, exhibit distinct spectral characteristics in the collision-induced dissociation (CID) tandem
mass (MS/MS) spectra that are described here. The MS/MS spectra typically display two dominant
peaks whose m/z values correspond to neutral losses of [H3PO4] (98 Da) and the PLP moiety as
[C8H10NO5P] (231 Da) from the precursor peptide ion, respectively. Few other peaks are observed.
Recognition of this distinct fragmentation behavior is imperative since determining sequences and
sites of modifications relies on the formation of amide backbone cleavage products for subsequent
interpretation via proteome database searching. Additionally, PLP-modified peptides exhibit sup-
pressed precursor ionization efficiency which diminishes their detection in complex mixtures.
Presented here is a protocol which describes an enrichment strategy for PLP-modified peptides
combined with neutral loss screening and peptide mass fingerprinting to map the PLP-bonding site
in a known PLP-dependent protein. This approach represents an efficient alternative to site-directed
mutagenesis which has been the traditional method used for PLP-bonding site localization in
proteins. Copyright # 2009 John Wiley & Sons, Ltd.We present here a mass spectrometry (MS)-basedmethod for
determining the active-site lysine bonding residue to
pyridoxal-50-phosphate (PLP) in PLP-dependent enzymes.
PLP is a unique post-translational modification (PTM)
involved in catalyzing an assortment of reactions including
decarboxylation, amino group transfers, and isomerization
of amino acids.1,2 PLP-bonding sites have traditionally been
determined using site-directed mutagenesis combined with
spectroscopy and activity assays.3,4 The application of MS
was considered here as an alternative to the laborious and
time-consuming mutagenic approach due to the demon-
strated success of MS for mapping other post-translational
modifications (PTMs) in proteins.5 Tandem mass spectrom-
etry (MS/MS) combined with proteome sequence databases
and database search tools such as Mascot6 have allowed for
the high-throughput analysis of large MS/MS spectral
datasets for the interpretation of peptide sequences and
PTMs.7 When combined with multiple fractionation tech-
niques like cation exchange and reversed-phase liquid
chromatography (RP-LC), which are commonly employed
in bottom-up proteomic protocols, thousands of peptides canndence to: E. S. Simon, Department of Biological Chem-
versity of Michigan, 300 N. Ingalls St., Ann Arbor, MI
A.
ssimon@umich.edube analyzed leading to the identification of hundreds or
thousands of proteins.8 However, database search tools rely
on backbone fragmentation for sequence interpretation.
Some labile modifications on peptides can be unaccommo-
dating to this approach as fragmentation often results in the
selective, facile cleavage of the modification from the peptide
ion. Phosphopeptides, for example, preferably release
neutral [H3PO4] from the side chain of a residue concomitant
with a lack of backbone fragmentation.9,10 The resultingMS/
MS spectrum is often devoid of peaks that can be used to
elucidate sequence information. Reported here is another
such case where we have observed a selective, yet distinctive
fragmentation pattern of peptides reductively aminated at
lysine residues by PLP when analyzed via collision-induced
dissociation (CID) tandem mass spectrometry. MS/MS
spectra of PLP-modified peptides exhibit two dominant
peaks representing product ions corresponding to neutral
losses of [H3PO4] and [C8H10NO5P] (representing the PLP
moiety itself), respectively. Few other peaks are observed.
In addition to the low yield of sequence ion peaks
generated from PLP-modified peptides in MS/MS spectra,
there are other challenges to address when applying MS for
bonding site localization. Among these challenges is the
covalent Schiff base that is formed between PLP and
proteins.2,11 Since it is reversible,12,13 the Schiff base must
be converted into a stable secondary amine via reductionCopyright # 2009 John Wiley & Sons, Ltd.
Figure 1. ESI-MS/MS spectra of (A) singly, (B) doubly, and (C) triply charged precursor ions of a PLP-modified
peptide with the amino acid sequence HHLGGAKQAGDV. Inset: NaBH4 reduction of the Schiff base of a PLP-
modified lysine residue.
3402 E. S. Simon and J. Allisonwith sodium borohydride, NaBH4 (inset Fig. 1), to prevent
dissociation during sample preparation.14,15 Stabilization is
not a normal consideration for other PTMs likemethylation16
and phosphorylation17 whose covalent attachments remain
stable during protein denaturation and digestion. Another
challenge, evident from our study here, is that PLP-modified
peptides exhibit reduced detection efficiency relative to
unmodified peptides. This is not surprising since phospho-
peptides exhibit similar behavior.18 As a result, an enrich-
ment strategy for PLP-modified peptides may be necessary
to detect them in complex mixtures.
We report here a method for assigning PLP-bonding sites
in proteins by combining the recognition of a distinct
fragmentation pattern of peptides modified by PLP (at lysine
residues via reductive amination) with peptide mass finger-
printing.19 Fragmentation yields almost exclusively two
product ions representing the neutral losses of phosphoric
acid [H3PO4] and the PLPmoiety [C8H10NO5P], respectively.
The lack of backbone fragmentation results in MS/MS
spectra completely devoid of sequence information discern-
able by manual interpretation or database search tools.
However, we demonstrate that precursor m/z values of MS/
MS spectra exhibiting the signature peaks of PLP-modified
peptides can be mapped to in silico peptides for accurately
assigning the active-site PLP bonding residue. In addition,
we present an enrichment strategy for detecting PLP-
modified peptides using LC/MS/MS. These protocols are
demonstrated on a known PLP-dependent enzyme; alanine
racemase (Bacillus stearothermophilus; MW¼ 44 kDa).20Copyright # 2009 John Wiley & Sons, Ltd.EXPERIMENTAL
Chemicals
All materials and chemicals were purchased from Sigma-
Aldrich (St. Louis, MO, USA) unless otherwise stated.
Synthesis and LC/MS/MS analysis of a PLP-
modified peptide
A PLP-modified peptide was synthesized by incubation of
the peptide (sequence HHLGGAKQAGDV) in 200mL of
100mM N-2-hydroxyethylpiperizine-N0-ethanesulfonic acid
(HEPES) (pH 7.8) with a saturating amount of PLP and 5mL
of 1MNaBH4 for 1 h in the dark. The reaction products were
then analyzed via LC/MS/MS using a Bioanalyzer LC
system fromMichrom Bioresources, Inc. (Auburn, CA, USA)
with a reversed-phase C18 column (5mm, 300 Å, 2.0 150mm;
Reliasil, Ontario, CA,USA).An acetonitrile gradient (5–80%) in
0.1% trifluoroacetic acid (TFA) was employed at a flow rate of
65mL/min. The LC system was connected in-line to a LCQ
Deca ion trap mass spectrometer (ThermoFisher Scientific,
Inc., San Jose, CA, USA) operated in data-dependent mode.
A total of 3 106 ions were targeted per MS scan and 1 106
precursor ions were targeted for isolation for MS/MS
spectral acquisition. A source voltage of 2.90 kV and capillary
temperature of 2208C were applied.
NaBH4 reduction of the Schiff base in alanine
racemase
About 300mg of alanine racemase (lyophilized powder
containing a substoichiometric amount of PLP) was dis-Rapid Commun. Mass Spectrom. 2009; 23: 3401–3408
DOI: 10.1002/rcm
Assignment of PLP-bonding sites with MS/MS 3403solved in 200mL of 100mM HEPES (pH 7.8) and 5mL of 1M
NaBH4 (also dissolved in HEPES buffer) was added to
reduce the Schiff base. The reduction reaction was allowed to
proceed undisturbed for 1 h in the dark. UV-visible spectra of
alanine racemase were acquired (scan range 300–500 nm)
using a DU 530 Life Sciences UV/VIS spectrophotometer
(Beckman Coulter, Fullerton, CA, USA) before reduction to
confirm the presence of PLP linked by a Schiff base and after
reduction to confirm the presence of a reduced Schiff base
(band at 325 nm; data not shown). The protein was then
dialyzed against 25mM ammonium bicarbonate (pH 7.8).
Proteolytic digestion and CNBr cleavage of the
enzymes
Before digestion, disulfide bonds were reduced with 5mL of
200mM dithiothreitol (DTT) (1 h incubation at room
temperature (RT)) and the cysteine residues were alkylated
with 20mL of 200mM iodoacetamide (IAA) (1 h incubation at
RT in the dark). The alkylation reaction was quenched with
20mL of 200mM DTT (1 h incubation at RT). After drying to
an approximate volume of 5mL, the enzyme was diluted in
100mL of cyanogen bromide (CNBr) solution (2mg/mL
CNBr in 70% formic acid pre-purged with N2 gas) and
incubated at RT in a fume hood for 2 h in the dark. The
mixture was dried under N2 gas and redissolved in water.
CNBr fragments were separated by HPLC on a reversed-
phase C4-packed column (5mm, 300 Å, 1.0 150mm; Grace-
Vydac, Deerfield, IL, USA) and fractions corresponding to
chromatographic peaks (detected at 214 nm) were collected
and screened for the presence of a reduced Schiff base (band
at 325 nm; data not shown) using scanning mode UV-
visible spectroscopy. The Schiff base-containing fraction was
dried and diluted in 25mM ammonium bicarbonate (pH 7.8)
and digested with 4mg of trypsin (Promega, Madison, WI,
USA), overnight at 378C.
LC/MS/MS and data analysis of digestion
products of Schiff base-containing CNBr
fragments
The resulting tryptic digestion products were analyzed via
LC/MS/MS using a reversed-phase C18 column (5mm,
300 Å, 2.0 150mm; Reliasil, Ontario, CA, USA). The same
LC and MS conditions were used as described above. MS/
MS peak lists from the raw files were extracted (.dta format)
using BioworksBrowser version 3.3.1 SP1 (ThermoFisher
Scientific Inc., San Jose, CA, USA). The .dta files were then
converted into .mgf format (as one concatenated file) using a
Perl script (merge.pl) available from Matrix Science Inc.
(Boston, MA, USA). The .mgf file was then analyzed with the
Mascot database searching software fromMatrix Science Inc.
(Boston, MA, USA) using the complete Swiss-Prot proteome
database (release 56.9).21 The following fixed settings and
modifications were used in the searches: trypsin as the
protease; carbamidomethylation (C); and the precursor and
product ion mass tolerances were set at 1 Da. The variable
modifications included deamidation (N and Q), oxidation
(M), homoserine lactone (M), and PLP (K). Lysine incurs a
mass increase of 231.030 Da (residue mass¼ 359.125 Da)
upon reduction of the Schiff base linking it to PLP.14,15
Peptide identifications and residue modifications wereCopyright # 2009 John Wiley & Sons, Ltd.accepted if their search scores were above the confidence
threshold (95% confidence interval) as established by Mascot.RESULTS
CID fragmentation MS/MS spectra of peptides
reductively aminated to PLP
Our initial experimental design for mapping PLP modifi-
cations in proteins included reduction of the Schiff base with
NaBH4, digestion of the protein with trypsin, LC/MS/MS
analysis, and data processing with Mascot. This approach
failed to yield any evidence of a peptide carrying a PLP
modification. Since a phosphate group is part of the PLP
moiety, it was hypothesized that perhaps poor backbone
fragmentation9,10 and/or reduced detection efficiency (per-
haps due to ion suppression or low stoichiometry) of the
precursor ion of the modified peptide may have contributed
to the undetected modification18 as these are common
characteristics of phosphopeptides when analyzed by MS.
This prompted us to synthesize a PLP-modified peptide as
a model to test our hypotheses and analyzed it by CID. The
MS/MS spectra for this peptide (sequence HHLGGAK-
QAGDV) as þ1, þ2, and þ3 charged precursor ions are
displayed in Figs. 1(A), 1(B), and 1(C), respectively. The
spectra suggest that fragmentation is primarily limited to the
losses of [H3PO4] (98 Da) and [C8H10NO5P] (231 Da),
referred to here as the PLP moiety (inset Fig. 1), from the






although in Fig. 1(C) the loss of the PLP moiety was
accompanied by the loss of an additional mass unit and one
charge unit [(MH3)
3þ–(C8H11NO5P)
þ]2þ. The precursor ion
MS scans (data not shown) showed that the products from
the reduction reaction included a mixture of unmodified
peptide with a proportion of peptide carrying a single PLP
modification. For the population of ions carrying a single PLP
modification, we cannot be sure if the modification occurred
primarily on the side-chain lysine amino group, on the N-
terminus, or in a mixture of the two sites using this analytical
approach. However, this experiment provided some insight
into the effect that a reductively aminated PLP modification
has on the fragmentation of peptides with CID. For
comparison, MS/MS spectra of the underivatized peptide
are displayed in Fig. 2. Contrary to the PLP-modified analog,
the underivatized peptide exhibits significant backbone
fragmentation. A scarcity of sequence ion peaks could
represent one explanation why a PLP modification from the
alanine racemase digestion mixture went undetected by
Mascot. However, manual screening of the dataset found no
MS/MS spectra exhibiting these characteristics.
Enrichment of the PLP-modified CNBr-
generated fragment of alanine racemase
It was then considered that reduced detection efficiency was
a second contributing factor to detecting the elusive
modification based analogously to phosphopeptides which
exhibit ion suppression and lower stoichiometry relative to
nonphosphorylated peptides.18,23 Therefore, an enrichment
scheme for PLP-modified peptides was then applied to
reduce the complexity of the peptide mixture resulting fromRapid Commun. Mass Spectrom. 2009; 23: 3401–3408
DOI: 10.1002/rcm
Figure 2. ESI-MS/MS spectra of (A) singly and (B) doubly charged precursor ions of the underivatized standard
peptide with the amino acid sequence HHLGGAKQAGDV.
3404 E. S. Simon and J. Allisonthe tryptic digestion of the protein. The general scheme
included the following steps subsequent to NaBH4 reduction
of the Schiff base, reduction of disulfide bonds, and
alkylation of cysteine residues: (1) The protein was treated
with CNBr which chemically cleaves the amide backbone on
the C-terminal side of methionine residues converting them
into a homoserine lactone.22 Since methionine occurs at a low
frequency in most proteins, this typically generates fairly
large peptide fragments. (2) The CNBr fragments were
separated by HPLC and fractions corresponding to chroma-
tographic peaks (detected at 214 nm) were collected. (3) The
fractions were then screened using UV-visible spectroscopy
for the characteristic band (325 nm) of a PLP modification
with a reduced Schiff base.14,15 Figure 3 displays a HPLC
chromatogram of the separated CNBr fragments of alanine
racemase. The inset shows a UV-visible spectrum of the
fraction corresponding to the chromatographic peak marked
with an asterisk in the chromatogram. The distinctive band at
325 nm was only observed in this fraction implying the PLP
modification resided within that fragment of the protein.
Identification of the PLP-modified CNBr
fragment
The HPLC fraction containing the PLP-modified CNBr
fragment was digested with trypsin and two aliquots of the
resulting peptide mixture were analyzed via LC/MS/MS.Copyright # 2009 John Wiley & Sons, Ltd.While it was considered to try and analyze the CNBr-
generated products directly, we decided to proteolyze
further with trypsin considering that CNBr fragments are
typically too large to yield informative MS/MS spectra. The
data were processed with Mascot using a PLP modification
(with a reduced Schiff base linkage) as a variable modifi-
cation on lysine among the other search parameters. Table 1
lists the peptides identified by Mascot. With the exception of
peptide #1 in the table, all peptides detected reside in the
theoretical CNBr fragment A36-M130 suggesting that the
PLP modification resides within that fragment. There are
three lysine residues within that fragment of the protein
(K39, K76, and K129) representing possible sites of PLP
modification. However, there were no PLP-modified pep-
tides identified when the data was analyzed byMascot. Only
unmodified K129 was detected within the fragment. It is
assumed that unmodified K39 and K76 would not be
detected since cleavage at these sites would result in peptides
too small to be analyzed by the instrumentation used. Coverage
at these sites would more likely be observed if there was a
missed tryptic cleavage event or a PLP modification since
lysine residues aminated by PLP resist cleavage by trypsin.14,15
Furthermore, detection of any unmodified lysine residue could
not be ruled out as the PLP-bonding site since the content of
PLPwas sub-stoichiometric relative to the protein (according
to the distributor). Nonetheless, this experiment narrowedRapid Commun. Mass Spectrom. 2009; 23: 3401–3408
DOI: 10.1002/rcm
Figure 3. HPLC chromatogram of CNBr-generated fragments of alanine racemase. The Schiff base-linked PLP
modification was previously reduced with NaBH4. The chromatographic peak marked with an asterisk represents the
single fraction exhibiting a UV-visible spectrum (inset) with a band at 325 nm characteristic of a reduced Schiff base
linkage of PLP to a lysine residue.
Assignment of PLP-bonding sites with MS/MS 3405the PLP-bonding site possibilities from thirteen total lysine
residues in the protein to just three.Identification of the PLP modification site with
neutral loss scanning combined with peptide
mass fingerprinting
PLP modification sites were assigned by using the software
Excalibur (ThermoFisher Scientific Inc., San Jose, CA, USA)
for neutral-loss screening for MS/MS spectra exhibiting
distinctive product ion peaks diagnostic for PLP-modified
peptides followed by manual peptide mass fingerprinting.
With K39, K76, and K129 representing the candidate PLP-
bonding sites in alanine racemase, we scanned the MS/MSTable 1. Peptides identified from the CNBr fragment A36-M130 o








The HPLC fraction containing this fragment exhibited a UV-visible spect
the enzyme.
Copyright # 2009 John Wiley & Sons, Ltd.spectra in the dataset for those that exhibited the character-





nþ, that were observed when the model peptide
was analyzed (Fig. 1). Since the model peptide exhibited loss
of both [H3PO4] and the PLP moiety, MS/MS scans
displaying peaks for both neutral losses were examined.
As displayed in Fig. 4, the MS/MS spectra were screened for
both neutral loss products characteristic to PLP-modified
peptides. Figure 4(A) displays the precursor ion base-peak
chromatogram and Fig. 4(B) displays a chromatogram
plotting the intensities of any product ions in the MS/MS
spectra (annotated by their scan numbers) corresponding to a
neutral loss of [H3PO4] from the precursor ion m/z value. In
this case, triply charged precursor ions were consideredf alanine racemase
Residue #s Run #
1 to 6 1
40 to 52 1, 2
53 to 61 2
62 to 74 1, 2
77 to 100 2
101 to 107 2
108 to 129 1
rum characteristic of a reduced Schiff base linkage between PLP and
Rapid Commun. Mass Spectrom. 2009; 23: 3401–3408
DOI: 10.1002/rcm
Figure 4. The base-peak precursor ion chromatogram from the LC/MS/MS analysis of the tryptic products of the
CNBr fragment A36-M130 of alanine racemase (A) along with the corresponding plots of characteristic neutral losses
of H3PO4 (B) and the PLP moiety (C) product ion signals respectively from triply charged precursor ions. The plots
were constructed by scanning for losses of 32.7 (B) and 77m/z units (C), respectively.
3406 E. S. Simon and J. Allisonwhich would incur a loss of 32.7m/z units (98 Da) upon
the loss of [H3PO4]. Figure 4(C) displays the corresponding
chromatogram for the neutral loss of the PLP moiety which
would incur a loss of 77m/z units (231 Da) from the
precursor ion. The data was also screened in this fashion for
the neutral loss peaks from doubly charged precursor ions
(data not shown). Since both neutral loss products are
characteristic of PLP-modified peptides, scans that produced
product ion signals for both (such as scan 903 in Figs. 4(B)
and 4(C)) were analyzed manually. Figures 5(A) and 5(B)
display representative MS/MS spectra from a doubly and
triply charged precursor ion (m/z values 993.75 and 663.00,
respectively) which exhibit these spectral features along with
a scarcity of peaks representing evidence of other fragmenta-
tion events. The lack of sequence ion peaks explains why
neither of these spectra could be matched to a peptide by
Mascot. Table 2 lists theoretical tryptic products from the
CNBr fragment A36-M130 that represent possible PLP-
modified peptides. The precursor m/z values 993.75 andTable 2. Possible theoretical PLP-modified peptides from fragme




K0 represents a reductively aminated PLP modification on lysine. Homo
Copyright # 2009 John Wiley & Sons, Ltd.663.00 representing the spectra in Fig. 5 most closely
match the theoretical mass of the fragment 36-52,
AVVK0ANAYGHGDVQVAR, in itsþ2 andþ3 charge states,
respectively, including the mass of the PLP moiety on the
modified lysine residue (K0). Despite exhibiting lower mass
accuracy compared to current instrumentation, the LCQ ion
trap is adequate for this application considering that the
sample consists of a simplified peptide mixture generated
from the enrichment of a fragment of a single purified
protein of known sequence. Since the peptide has one
lysine residue, K39, the PLP-bonding site can be unambi-
guously assigned to this residue. This agrees with the
known PLP-bonding site in alanine racemase.20 It is
noteworthy that PLP-modified peptides exhibited poor
chromatographic resolution compared to unmodified pep-
tides as evident by the broadness of the elution profiles
displayed in Figs. 4(B) and 4(C). This could also represent a
contributing factor to the difficulty in detecting them in






36 to 52 993.48 662.66
75 to 100 1438.76 959.51
108 to 130 1429.66 953.45
serine lactone is represented by h.
Rapid Commun. Mass Spectrom. 2009; 23: 3401–3408
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Figure 5. ESI-MS/MS spectra of the PLP-modified tryptic peptide 36-52, AVVK0ANAYGHGDVQVAR, of alanine
racemase. The MS/MS spectra represent the doubly charged precursor ion, m/z 993.75 (A), and the triply charged
precursor ion, m/z 663.00 (B).
Assignment of PLP-bonding sites with MS/MS 3407DISCUSSION
Peptides modified by PLP (reductively linked to a lysine side
chain) exhibit mass spectral characteristics similar to those
observed for phosphopeptides including impaired back-
bone fragmentation. Distinctive to PLP-modified peptides is
the neutral loss product corresponding to the PLP moiety
itself in addition to the loss of H3PO4. Like phosphopeptides,
the lack of backbone fragmentation with CID results in MS/
MS spectra that provide little sequence information. We
demonstrated an enrichment procedure that enhances
detection of PLP-modified peptides by first cleaving the
protein with CNBr, separating the fragments, and then
digesting the fraction exhibiting a characteristic UV-visible
spectrum of a reduced Schiff base linkage of PLP to lysine.
This results in a much simpler peptide mixture relative to
digesting the intact protein with trypsin and reduces the
number of candidate lysine residues that may represent the
PLP-bonding site. Although processing of the data with
Mascot did not yield a peptide hit with a PLP modification,
the peptides identified showed that the modification was
sequestered within the fragment A36–M130 of the protein.
We then demonstrated the mapping of the PLP-bonding site
by employing neutral loss screening of all MS/MS spectra
combined with peptide mass fingerprinting. Our results
provide foresight to future investigators who can now
anticipate the mass spectral characteristics and limitations
when attempting to locate PLP modification sites in proteins
using CID tandem mass spectrometry. In future studies,
alternative enrichment strategies may be applied such asCopyright # 2009 John Wiley & Sons, Ltd.immobilized metal-affinity chromatography23 or metal
oxides24 that have been effective in phosphorylation site
mapping. Alternative fragmentation techniques to CID, such
as electron transfer dissociation,25 electron capture dis-
sociation26 or neutral-loss triggered MS3 acquisition,27 have
been effective for analyzing peptides with labile modifi-
cations and may also be applicable to PLP modifications.
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